Oncology & Cancer

Rare angiosarcoma tumors respond well to immunotherapy combination

Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute's (NCI) Division of Cancer Diagnosis and Treatment (DCTD), part of the National Institutes of Health, have ...

Surgery

Percutaneous ablation vs. surgery for hepatocellular carcinoma

Compared to surgery, percutaneous liver ablation interventions (IRs) in patients with hepatocellular carcinoma (HCC) are associated with lower inhospital mortality, length of hospital stay (LOS), and hospitalization costs, ...

page 1 from 5